CytomX Therapeutics, Inc. (CTMX)
4.30
+0.21
(+5.13%)
USD |
NASDAQ |
Jan 14, 16:00
4.29
-0.01
(-0.23%)
Pre-Market: 20:00
CytomX Therapeutics Market Cap: 728.57M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 10.77B |
| NovaBay Pharmaceuticals, Inc. | 1.604B |
| Palatin Technologies, Inc. | 15.63M |
| Theriva Biologics, Inc. | 6.772M |
| Oragenics, Inc. | 0.757M |
Market Cap Related Metrics
| PE Ratio | 10.28 |
| PS Ratio | 4.364 |
| PEG Ratio | 0.0701 |
| Price to Book Value | 6.784 |
| Price | 4.30 |
| Earnings Yield | 9.73% |
| PEGY Ratio | 0.0701 |
| Operating PE Ratio | 21.43 |
| Normalized PE Ratio | 10.29 |